Subscribe
Rentokil is a good business with a good strategy for growth markets. This has served shareholders well in the past and looks likely to do so in the future.
Judges Scientific has bought good companies at great prices and kept them growing. This is an excellent business with a price tag to match but one that may still reward patient long-term investors.
Genus' scarcity value means its shares are expensive, but long-term investors could still do well from owning them
Free cash flow is widely used by investors – however, it is easy to make mistakes with it. While profits are sometimes treated with suspicion they can be better numbers to weigh up companies
Nichols has a great asset in Vimto, but Covid-19 has derailed its growth strategy for its out-of-home business. Can it get back on track when normal times return?
People are right to compare tech IPO valuations with the late 1990s, but established tech companies still have lots to offer investors
The ecommerce site is a business that faces a lot of challenges but it still has many attractions according to Phil Oakley. The shares are arguably too cheap
Sale and leasebacks have become commonplace in 2020. They can be good and bad for investors. Here's what you need to consider
The video games developer has laid the foundations for significant growth over the next few years
Domino’s was struggling to grow its profits before the pandemic hit